1. Signaling Pathways
  2. Antibody-drug Conjugate/ADC Related
  3. Radionuclide-Drug Conjugates (RDCs)
  4. RDC Bifunctional Chelator Isoform

RDC Bifunctional Chelator

RDC bifunctional chelators (BFC) serve two purposes: (1) to secure the radiometal ion and (2) to provide a covalent link between the complex and the targeting vector. BFCs are normally adapted from nonbifunctional analogues through the addition of pendant arms bearing a functional group available for facile bioconjugate coupling. DOTA and its derivatives are one of the most widely used bifunctional chelating agents.

RDC Bifunctional Chelator Related Products (58):

Cat. No. Product Name Effect Purity
  • HY-W034551
    DOTA-tri(t-butyl ester)
    99.46%
    DOTA-tri(t-butyl ester) can be used in the synthesis of generations 3 (G3) nanoglobular magnetic resonance imaging (MRI) contrast agents for MR angiography and tumor angiogenesis imaging.
  • HY-W087027
    Maleimide-NOTA
    99.69%
    Maleimide-NOTA is a chelator for the labeling of peptides and antibodies. Maleimide-NOTA can react with cysteine.
  • HY-W087028
    NOTA-NHS ester
    NOTA-NHS ester is a molecule related to radiolabeling drugs (RDC) that can be used for fluorescent labeling and radioactive nuclide labeling applications.
  • HY-W250574
    NOTA-bis(tBu)ester
    NOTA-bis(tBu)ester (NOTA-bis(t-Butyl ester)), a NOTA derivative, is a bifunctional chelator that can be used for drug coupling.
  • HY-136641
    NOTA-FAPI
    99.26%
    NOTA-FAPI is a fibroblast activation protein (FAP) inhibitor. NOTA-FAPI can be used as a probe for FAP-targeted tumour imaging. NOTA-FAPI has good tumour detection efficacy and excellent imaging quality.
  • HY-W087187
    DOTAGA-anhydride
    DOTAGA-anhydride is a DOTA-based metal chelator that can bind to radionuclides and is used to prepare radionuclide drug conjugates (RDCs). DOTAGA-anhydride can be used to label monoclonal antibodies (mAbs) such as trastuzumab (targeting HER2/neu receptor with an affinity of 5.5 nM) under mild conditions (PBS pH 7.4, 25 °C, 30 minutes) after chelation with indium-111. [111In-DOTAGA]-trastuzumab showed a tumor uptake of 65% ID/g in mice bearing breast cancer BT-474 xenografts 72 hours after injection, which is valuable for SPECT/CT imaging and biodistribution studies.
  • HY-164589
    NOPO
    NOPO is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy.
  • HY-157977
    DOTA-GA-maleimide
    99.26%
    DOTA-GA-maleimide is a macrocyclic chelator, which forms stable complex with metals. DOTA-GA-maleimide is utilized as radiolabelled imaging agent.
  • HY-134418
    NOTA
    ≥98.0%
    NOTA is a bifunctional chelate which acts as the framework to construct PET imaging tools. NOTA also can be used for probe design and signal amplification via the multivalent effect.
  • HY-155483
    PSMA-BCH
    99.93%
    PSMA-BCH (NOTA-PSMA) is a NOTA-conjugated precursor. NOTA is a bifunctional chelate which acts as the framework to construct PET imaging tools.
  • HY-100138
    2-Aminoethyl-mono-amide-DOTA-tris(tBu ester)
    ≥98.0%
    2-Aminoethyl-mono-amide-DOTA-tris(tBu ester) is a macrocycle DOTA derivative for tumor pretargeting.
  • HY-132989
    Mal-Deferoxamine
    Mal-Deferoxamine is a maleamide (Mal)-containing Deferoxamine (HY-B1625). Mal selectively covalently binds to sulfur groups to produce a linking reaction. Mal-Deferoxamine can be combined with radionuclides to synthesize radionuclide drug conjugates (RDCs). RDCs have the ability to specifically target biomolecules and can be used in medical imaging or therapy..
  • HY-W539916
    Azido-mono-amide-DOTA
    99.96%
    Azido-mono-amide-DOTAis a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DOTA derivative used for tumor pre-targeting. Azido-mono-amide-DOTA can be used for conjugation of peptides and radionuclides.
  • HY-W717743
    DOTAM-mono-acid
    ≥98.0%
    DOTAM-mono-acidis a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DOTA derivative used for tumor pre-targeting. DOTAM-mono-acid can be used for conjugation of peptides and radionuclides.
  • HY-W614269
    DOTA-GA(tBu)4
    ≥98.0%
    DOTA-GA(tBu)4 is a macrocyclic chelator used in medical imaging.
  • HY-W782083
    p-SCN-Bn-NOTA trihydrochloride
    99.62%
    p-SCN-Bn-NOTA (trihydrochloride)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic NOTA derivative used for tumor pre-targeting. p-SCN-Bn-NOTA (trihydrochloride) can be used for conjugation of peptides and radionuclides.
  • HY-160607
    MMA-NODAGA
    MMA-NODAGA is a chelator for site-specific labeling of targeting proteins containing unpaired cysteine. MMA-NODAGA can be used to conjugate with exosome and 64Cu in image with positron emission tomography (PET)<[2].
  • HY-158067
    Deferoxamine-DBCO
    Deferoxamine-DBCOis a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DFO derivative used for tumor pre-targeting. Deferoxamine-DBCO can be used for conjugation of peptides and radionuclides.
  • HY-W782078
    Butyne-DOTA
    ≥98.0%
    Butyne-DOTAis a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DOTA derivative used for tumor pre-targeting. Butyne-DOTA can be used for conjugation of peptides and radionuclides.
  • HY-W749627
    NO2A-Butyne
    ≥98.0%
    NO2A-Butyneis a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic NOTA derivative used for tumor pre-targeting. NO2A-Butyne can be used for conjugation of peptides and radionuclides.